Exact Sciences Corporation Share Price Mexican S.E.
Stocks
EXAS *
US30063P1057
Biotechnology & Medical Research
| Market Cap | 20.03B 350B 17.52B 16.16B 14.92B 28.32B 1,910B 28.79B 193B 75.81B 941B 75.19B 73.56B 3,235B | P/E 2024 |
-10.1x | P/E 2025 | -92.2x |
|---|---|---|---|---|---|
| Enterprise Value | 21.6B 378B 18.89B 17.42B 16.09B 30.54B 2,060B 31.05B 208B 81.75B 1,015B 81.09B 79.32B 3,488B | EV / Sales 2024 |
4.4x | EV / Sales 2025 | 6.42x |
| Free-Float |
98.24% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Exact Sciences Corporation
| 1 day | -15.23% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -15.23% | +9.18% | - | - | 20.03B | |
| -3.93% | -0.19% | +110.38% | +108.07% | 4.55B | |
| -3.39% | -0.61% | +78.17% | +203.46% | 3.37B | |
| +4.20% | -1.15% | -27.01% | -39.95% | 2.05B | |
| -3.20% | -1.86% | +126.20% | -46.66% | 1.89B | |
| -2.06% | -2.33% | +41.63% | +175.73% | 1.47B | |
| +2.01% | +0.83% | +123.08% | -50.04% | 898M | |
| +6.42% | -1.19% | -10.08% | +43.92% | 880M | |
| +1.63% | -3.18% | -36.79% | -18.41% | 483M | |
| +7.05% | +1.07% | -2.63% | - | 487M | |
| Average | -0.65% | -0.80% | +44.77% | +47.01% | 1.79B | |
| Weighted average by Cap. | -8.95% | -0.66% | +67.94% | +80.23% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.76B 48.26B 2.41B 2.23B 2.06B 3.9B 263B 3.97B 26.6B 10.44B 130B 10.36B 10.13B 446B | 3.25B 56.8B 2.84B 2.62B 2.42B 4.59B 310B 4.67B 31.3B 12.29B 153B 12.19B 11.93B 524B |
| Net income | -1.03B -18B -900M -830M -767M -1.45B -98.13B -1.48B -9.92B -3.89B -48.34B -3.86B -3.78B -166B | -208M -3.64B -182M -168M -155M -294M -19.83B -299M -2B -787M -9.77B -781M -764M -33.59B |
| Net Debt | 1.74B 30.4B 1.52B 1.4B 1.29B 2.46B 166B 2.5B 16.75B 6.58B 81.65B 6.52B 6.38B 281B | 1.57B 27.46B 1.37B 1.27B 1.17B 2.22B 150B 2.26B 15.14B 5.94B 73.77B 5.9B 5.77B 254B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
